https://clinicaltrials.gov/ct2/show/NCT04079088?type=Intr&cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14
Condition : Relapsing Multiple Sclerosis
Interventions : Drug: Placebo; Drug: BIIB061; Biological: Interferon-beta1
Sponsor : Biogen
Not yet recruiting
Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) in Relapsing Multiple Sclerosis (RMS)
NCT04079088
Thu, 05 Sep 2019 12:00:00 EDT
First Added: 09/06/19 06:57AM